Vital Therapies, Inc. (VTL): New Bullish Coverage

VTL – Raymond James initiates as an outperform, $6PT. This price target represents a 110.53% upside over the stock’s previous closing price of $2.85.


Update: As of Dec. 11, 2017, this bullish analyst call has returned 70.18%.


Key Facts Surrounding This News Item


  • VTL had a POWR Rating of F (Strong Sell) coming into today.
  • VTL was -16.86% below its 10-Day Moving Average coming into today.
  • VTL was -21.30% below its 20-Day Moving Average coming into today.
  • VTL was -26.46% below its 50-Day Moving Average coming into today.
  • VTL was -33.45% below its 100-Day Moving Average coming into today.
  • VTL was -43.29% below its 200-Day Moving Average coming into today.
  • VTL had returned -34.48% year-to-date leading up to today’s news, versus a +5.96% return from the benchmark S&P 500 during the same period.

More Info About Vital Therapies, Inc. (VTL)


Vital Therapies is a biotherapeutic company developing a cell-based therapy targeting the treatment of liver failure. The company was founded in 2003 and is based in San Diego, California. View our full VTL ticker page with ratings, news, and more.

VTL at a Glance

VTL Current POWR Rating™
Overall POWR Rating™
VTL Current Price $4.85 1.02%
More VTL Ratings, Data, and News

VTL Price Reaction

The day of this event (May. 18, 2017)
VTL Closing Price$2.60 8.77%
VTL Volume171,200
104.71% from avg
Leading up to this event
VTL 1-mo return22.97%
After this event
VTL 1-day return8.95%
VTL 3-day return10.94%
VTL 5-day return0.71%

VTL Price Chart



More Vital Therapies, Inc. (VTL) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VTL News
Page generated in 1.8989 seconds.